CA Patent

CA2586259A1 — Novel fused imidazole derivative

Assigned to MSD KK · Expires 2006-05-11 · 20y expired

What this patent protects

Disclosed is a compound represented by the general formula [I] below or a pharmaceutically acceptable salt or ester thereof. [I] [In the formula, the ring A represents a five-membered aromatic heterocyclic group containing at least one heteroatom selected from a nitrogen atom or …

USPTO Abstract

Disclosed is a compound represented by the general formula [I] below or a pharmaceutically acceptable salt or ester thereof. [I] [In the formula, the ring A represents a five-membered aromatic heterocyclic group containing at least one heteroatom selected from a nitrogen atom or the like; A1 and A2 represent nitrogen atoms or the like; all of X2, X3, X4 and X5 represent carbon atoms, or one of X2, X3, X4 and X5 represents a nitrogen atom and the rest represent carbon atoms; R1 represents a hydrogen atom or the like; R2, R3, R4 and R5 represent hydrogen atoms or the like; R6 and R6' represent hydrogen atoms or the like; R7 represents an aryl group or the like; and R8 represents an amino group or a hydroxy group.]

Drugs covered by this patent

Patent Metadata

Patent number
CA2586259A1
Jurisdiction
CA
Classification
Expires
2006-05-11
Drug substance claim
No
Drug product claim
No
Assignee
MSD KK
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.